MFine At-Home Lab and Diagnostic Service Records 3x Growth in 2021 with 60% Users from Non-metros

MFine At-Home Lab and Diagnostic Service Records 3x Growth in 2021 with 60% Users from Non-metros

MFine At-Home Lab and Diagnostic Service Records 3x Growth in 2021 with 60% Users from Non-metros

Listen to this Article

India’s leading Digital Health startup MFine today announced that its lab and diagnostic services have grown by over 3X in 2021. In October 2018, MFine added another layer to its virtual doctor consultations by integrating with laboratory services and now has over 300 lab partners in more than 400 cities in India. Over 75,000 users use MFine for booking at-home tests every month and around 500 users use the platform to book radiology appointments everyday. MFine has partnered with some of the best labs in the industry such as Thyrocare, Lal Path Labs, Healthians and many more to offer safe and prompt lab services to its users. As a telemedicine platform that provides end to end healthcare services, the company is targeting to add over 300 lab partners in 2021.

With the uptick in the adoption of online consultations and at-home lab and diagnostic services in India, MFine provides its users with access to more than 700 diagnostic centres across India. Additionally, the organisation offers a free analysis of the reports and follows international standards of safety protocols along with a strict adherence to Turn Around Time (TAT). What makes these services even more effective is the range of services offered on the platform from doctor consultations to lucrative discounts. While most of the lab and diagnostic services users are from metro cities like Delhi, Bengaluru and Mumbai, MFine witnessed a significant growth in customers from non-metro cities like Surat, Coimbatore and Ahmedabad.

As people continue to stay at home for preventative measures and seek medical treatment online, being able to access over 600 tests on MFine has aided in keeping people safe & more in control of their health during the pandemic. Among its wide array of lab tests, MFine also offers dedicated COVID-19 tests and diagnostics for its users. Apart from offering the standard RT-PCR test with a 24-hr report window to check the presence of active SARS-CoV-2 virus, MFine also offers the Cobid- antibody test which checks IgG Antibody Levels to indicate if one has been exposed to COVID-19 infection in the recent past. There are also Covid Inflammatory tests available for Covid positive patients to measure the severity of inflammation & Covid Infection which help in assessing the need for hospitalization and next steps of treatment. More than 150,000 Covid tests have been booked via MFine since the start of the pandemic, making it easier for hundreds of people to access the best possible care from their homes.

Since the pandemic, MFine has seen a gradual increase in the number of people booking regular and routine health checks. Full-body check-ups are the most sought after on the MFine platform indicating the increase in the adoption of preventive health checks in India. Regular health checks can help to identify early warning signs of disease or illness. Heart disease, diabetes and some cancers can often be picked up in their early stages, when treatment may be more successful. The company offers these tests along with a doctor/specialist consultation to help the user understand his condition and take immediate action.

Some key insights from MFine in the last six months:

  • The most active user group include- The 40+ age group

  • Full Body Checks, MRI and Thyroid tests account for the top three diagnostic services

  • Men and women user split stands at 55% vs 45% respectively

  • Metro vs non-metro split stands at 40% vs 60% respectively

With highly communicable diseases such as COVID-19 dictating staying at home and social distancing, mobile healthcare has become the most viable option for gaining quality healthcare at home. The ease of getting health-checks done at home, booking radiology appointments and getting a teleconsultation from a specialist is ushering a new era in preventive health, making people more informed and accountable for their own health.

Supporting Quotes

Arjun Choudhary, Founding Member & Chief Business Officer, MFine

“By integrating with labs and providing follow-up care services, MFine has taken a major step in advancing the quality and range of ailments treatable through telemedicine. For diagnostic services, we have seen an increasing number of users opting for home sample collection even after the second wave to avoid stepping out. With online diagnostic reports, consultation with the doctor and even prescribed medicines being delivered at home, users are getting used to the complete care that comes with MFine and our partners. We believe that through our partnership with leading lab partners, we can deliver diagnostics in a way that can better support early diagnosis and thereby have a profound impact on the health and well-being of patients.”

Jayraj Chauhan, Vice President- CEO’s office, Healthians

“After the onset of the Covid-19 pandemic, healthcare providers began embracing a higher degree of digital technology to deliver care that reduced the chances of transmitting the virus. Whether it is enabling the booking of diagnostics tests from the comfort of one’s home for any kind of health check-up or enabling patients to consult doctors virtually, these steps have empowered people to keep their health on track even during these tough times. Direct-to-patient diagnostics is the new paradigm that will not only play a major role in creating the best health outcomes for patients but will also prove to be a game-changer in terms of growing the health sector.”

Leave a Reply